ArticleGynecologic oncology reports2025
Percutaneous transesophageal gastrostomy in gynecologic oncology patients with symptomatic malignant bowel obstruction: A case series.
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Malignant bowel obstruction (MBO) is a frequent complication in patients with advanced gynecologic malignancies. Percutaneous transesophageal gastrostomy tubes (PTEG) were developed as an alternative in patients when percutaneous endoscopic gastrostomy (PEG) is technically difficult or clinically contraindicated. Clinical cases: Here we present three cases of women with gynecologic cancers with MBO who failed conservative or medical management and had a PTEG placed for palliative gastric decompression. No major complications were noted. Materials and methods: The procedures were successfully performed under general anesthesia by Interventional Radiologists. Under ultrasound and fluoroscopic guidance, a multipurpose drainage catheter was placed through the neck into the esophagus and positioned into the stomach. The catheter was then connected to drainage. Technical success was achieved in all the patients. Discussion: There are few palliative options for gastric decompression in patients who have advanced gynecologic malignancies. Both PEG and long-term nasogastric tube use have well-documented complications, especially in patients with large tumor burden and ascites. PTEG has been developed as a safe alternative with a low rate of complications and effective symptomatic relief in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.